Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Puma Biotechnology (PBYI) Return on Invested Capital (2021 - 2025)

Historic Return on Invested Capital for Puma Biotechnology (PBYI) over the last 5 years, with Q3 2025 value amounting to 0.23%.

  • Puma Biotechnology's Return on Invested Capital fell 600.0% to 0.23% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.23%, marking a year-over-year decrease of 600.0%. This contributed to the annual value of 0.27% for FY2024, which is 3000.0% down from last year.
  • Per Puma Biotechnology's latest filing, its Return on Invested Capital stood at 0.23% for Q3 2025, which was down 600.0% from 0.32% recorded in Q2 2025.
  • Puma Biotechnology's 5-year Return on Invested Capital high stood at 1.09% for Q1 2023, and its period low was 11.5% during Q1 2022.
  • Moreover, its 5-year median value for Return on Invested Capital was 0.26% (2025), whereas its average is 0.35%.
  • Its Return on Invested Capital has fluctuated over the past 5 years, first plummeted by -8900bps in 2022, then surged by 125900bps in 2023.
  • Quarter analysis of 5 years shows Puma Biotechnology's Return on Invested Capital stood at 0.9% in 2021, then crashed by -99bps to 0.0% in 2022, then skyrocketed by 8703bps to 0.42% in 2023, then tumbled by -44bps to 0.23% in 2024, then dropped by -4bps to 0.23% in 2025.
  • Its Return on Invested Capital stands at 0.23% for Q3 2025, versus 0.32% for Q2 2025 and 0.26% for Q1 2025.